Compare Enbridge Inc (ENB) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Heron Therapeutics Inc — how do they compare? Enbridge Inc trades at $56.38 (market cap $121.39B), while Heron Therapeutics Inc trades at $0.45 (market cap $84.50M). The key difference: Enbridge Inc is far larger — about 1436.6× Heron Therapeutics Inc's market cap, and Enbridge Inc pays a 5.01% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ENB | HRTX | |
|---|---|---|
Market Cap | $121.39B | $84.50M |
Sector | Energy | Health |
52-Week High | $58.04 | $2.02 |
52-Week Low | $44.59 | $0.39 |
Enterprise Value | $202.19B | $182.40M |
Dividend Yield | 5.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HRTX trades at $0.44, up 2.63% today, with a bullish technical signal but bearish moving averages. The company reported Q1 2026 revenue of $151M with a net loss of $31M, maintaining a negative profit margin of -20.53%. Recent patent litigation developments and mixed earnings performance create uncertainty, though analyst consensus remains overwhelmingly positive with 94.7% buy ratings.
The outlook remains challenging with persistent losses and negative cash flow from operations, though improving net cash flow trends offer some optimism. Key risks include ongoing patent litigation and execution challenges in achieving profitability. The strong analyst support suggests potential upside if the company can deliver on its guidance and improve operational efficiency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
